Cervical Cancer in the Province of Manitoba: A 30-Year Experience

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 9, 2008, Pages 788-795

  Gari, Abdulrahim ^a   Lotocki, Robert ^a   Krepart, Garry ^a   Popowich, Shaundra ^a   Demers, Alain ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

Author keywords

Cervical adenocarcinoma; Cervical cancer; Cervical carcinoma in situ; Cervical squamous cell carcinoma; Uterine cervix

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MANITOBA; SURVIVAL RATE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERUS CARCINOMA; ADENOCARCINOMA; CANADA; CARCINOMA IN SITU; INCIDENCE; MIDDLE AGED; REGISTER; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; MANITOBA; MIDDLE AGED; REGISTRIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 58149401470     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32943-7     Document Type: Article

References (34)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80(6):827-841.
2. National Cancer Institute of Canada Canadian Cancer Statistics 2002 2002, National Cancer Institute of Canada, Toronto (ON).
3. Canada Health Cervical Cancer Screening in Canada: 1998 Surveillance Report 1998, H39-H616. Health Canada, Ottawa (ON), Report No.: Cat No.
4. Day N.E. Effect of cervical cancer screening in Scandinavia. Obstet Gynecol 1984, 63:714-718.
5. Hristova L., Hakama M. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 1997, 36(Suppl 9):1-60.
6. Duguid H.L., Duncan I.D., Currie J. Screening for cervical intraepithelial neoplasia in Dundee and Angus 1962-81 and its relation with invasive cervical cancer. Lancet 1985, 2:1053-1056.
7. Taylor R.J., Morrell S.L., Mamoon H.A., Wain G.V. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J Epidemiol Community Health 2001, 55(11):782-788.
8. Gustafsson L., Ponten J., Zack M., Adami H.O. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997, 8(5):755-763.
9. National Cancer Institute of Canada Canadian Cancer Statistics 2000 2000, 17-38. National Cancer Institute of Canada, Toronto (ON).
10. Liu S., Semenciw R., Probert A., Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 2001, 164:1151-1152.
11. Olesen F. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int J Epidemiol 1988, 17(3):501-508.
12. Parazzini F., Negri E., La Vechia C., Bocciolone L. Screening practices and invasive cervical cancer risk in different age strata. Gynecol Oncol 1990, 38(1):76-80.
13. Sung H.Y., Kearney K.A., Miller M., Kinney W., Sawaya G.F., Hiatt R.A. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000, 88(10):2283-2289.
14. Stuart G.C., McGregor S.E., Duggan M.A., Nation J.G. Review of the screening history of Alberta women with invasive cervical cancer. CMAJ 1997, 157(5):513-519.
15. Smith H., Tiffany M., Qualls C., Key C. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol 2000, 78:97-105.
16. Bergstrom R., Sparen P., Adami H.O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999, 81:159-166.
17. Zheng T., Holdford T.R., Ma Z., Chen Y., Lui W., Ward B.A., et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol 1996, 25:252-258.
18. Armstrong B., Holman D. Increasing mortality from cancer of the cervix in young Australian women. Med J Aust 1981, 9:460-462.
19. Wharton V. Neoplasms of the cervix in Holland. Cancer medicine 1995, II:2227-2261. Williams & Wilkins, Toronto (ON). 4th ed.
20. Sasieni P., Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001, 357:1490-1493.
21. Canadian Socioeconomic Information and Management System website. Available at:. Accessed March 14, 2008. http://www.datacentre.chass.utoronto.ca:5680/cansim/cansim.html.
22. Committee on Nomenclature and Classification of Disease. Systematized Nomenclature of Pathology. Chicago, Illinois (IL): College of American Pathologists; 1969.
23. World Health Organization International Classification of Disease for Oncology 2nd ed 1990, World Health Organization, Geneva (CH).
24. National Cancer Institute of Canada Canadian Cancer Statistics 1999 1999, National Cancer Institute of Canada, Toronto (ON).
25. Kim H.-J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 2000, 19(3):335-351.
26. Breslow N.E., Day N.E. Rates and rate standardization. International Agency for Research in Cancer. The design and analysis of cohort studies 1987, 47-79. World Health Organaztion, Oxford (GB).
27. Selvin S. Statistical analysis of epidemiologic data 1996, Oxford University Press, New York (NY).
28. Department of Medical Epidemiology at Karolinska Institute in Stockholm. (SAS) codes developed by Paul Dickman. Available at:. Accessed March 14, 2008. http://www.pauldickman.com/teaching/toront02002/index.html.
29. Bulk S., Visser O., Rozendaal L., Verheijen R., Meijer C. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005, 113:1005-1009.
30. Vizcaino A., Moreno V., Bosch F., Munoz N., Barros-Dios X., Parkin M. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1989, 75:536-545.
31. Hemminki K., Li X., Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas in Sweden 1958-1996. Eur J Obstet Gynecol Reprod Biol 2002, 101:64-69.
32. Wang S., Sherman M., Hildesheim A., Lacey J., Devsa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004, 100:1035-1044.
33. Liu S., Semenciw R., Probert A., Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001, 11:24-31.
34. Davy M., Dodd T., Luke C., Roder D. Cervical cancer: effect of glandular cell type on prognosis, treatment and survival. Obstet Gynecol 2003, 101:38-45.